tiprankstipranks
CardieX Limited (CDEXF)
OTHER OTC:CDEXF

CardieX Limited (CDEXF) Stock Price & Analysis

2 Followers

CDEXF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.36 - $0.36
Previous Close$0.36
Volume0.00
Average Volume (3M)N/A
Market Cap
$12.88M
Enterprise Value$13.33M
Total Cash (Recent Filing)AU$1.46M
Total Debt (Recent Filing)AU$2.14M
Price to Earnings (P/E)
Beta0.11
Aug 29, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding109,953,700
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation2.93
R-Squared0.02
Alpha0.99
Financial Highlights & Ratios
Price to Book (P/B)6.75
Price to Sales (P/S)19.56
Price to Cash Flow (P/CF)13.30
P/FCF Ratio422.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

CDEXF FAQ

What was CardieX Limited’s price range in the past 12 months?
CardieX Limited lowest stock price was $0.36 and its highest was $0.36 in the past 12 months.
    What is CardieX Limited’s market cap?
    Currently, no data Available
    When is CardieX Limited’s upcoming earnings report date?
    CardieX Limited’s upcoming earnings report date is Aug 29, 2024 which is in 42 days.
      How were CardieX Limited’s earnings last quarter?
      CardieX Limited released its earnings results on Feb 29, 2024. The company reported $0.004 earnings per share for the quarter, beating the consensus estimate of N/A by $0.004.
        Is CardieX Limited overvalued?
        According to Wall Street analysts CardieX Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does CardieX Limited pay dividends?
          CardieX Limited does not currently pay dividends.
          What is CardieX Limited’s EPS estimate?
          CardieX Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does CardieX Limited have?
          Currently, no data Available
          What happened to CardieX Limited’s price movement after its last earnings report?
          CardieX Limited reported an EPS of $0.004 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
            Which hedge fund is a major shareholder of CardieX Limited?
            Currently, no hedge funds are holding shares in CDEXF
            ---

            CardieX Limited Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Fundamentals

            Return on Equity
            -411.74%
            Trailing 12-Months
            Asset Growth
            19.62%
            Trailing 12-Months

            Company Description

            CardieX Limited

            CardieX Ltd is a global health technology company, developing solutions for health disorders. Its AtCor Medical division develops and markets products for the early detection of target organ damage and management of a cardiovascular and renal disease. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia & Australia/New Zealand.
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Cidara Therapeutics
            Chromadex
            Codexis
            Cardax
            Popular Stocks
            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis